0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Insulin R

Insulin R

Insulin R Molecule Information

Name:Insulin receptor
Target Synonym:EC 2.7.10,EC:2.7.10.1,INSR,IR,Insulin receptor,CD220 Antigen,EC 2.7.10.1,CD220,HHF5,Receptor, Insulin
Number of Launched Drugs:52
Number of Drugs in Clinical Trials:52
Lastest Research Phase:Approved

Insulin R Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
INR-H52Ha Human Human Insulin R / CD220 (28-944) Protein, His Tag (SPR verified)
INR-H52Ha-structure
INR-H52Ha-sds
INR-H52Ha-elisa_1
INR-H52Ha-elisa_2

Insulin R Part of Bioactivity data

INR-H52Ha-SPR
Human_FcRn_Heterodimer_Protein_SPR

Human Insulin R (28-944), His Tag (Cat. No. INR-H52Ha) captured on CM5 chip via anti-His antibody, can bind Human Insulin with an affinity constant of 249 nM as determined in a SPR assay (Biacore T200) (QC tested).

INR-H52Ha-ELISA
Human Insulin R (28-944), His Tag (SPR verified)Human Insulin R (28-944), His Tag (SPR verified) (Cat. No. INR-H52Ha) ELISA bioactivity

Immobilized Human Insulin R (28-944), His Tag (Cat. No. INR-H52Ha) at 5 μg/mL (100 μL/well)can bind Human IGF-II, Fc Tag (Cat. No. IG2-H4260) with a linear range of 0.078-1.25 μg/mL (QC tested).

Insulin R Molecule Synonym Name

INSR,Insulin receptor,IR,CD220

Insulin R Molecule Background

Insulin receptor (INSR) is also known as CD antigen CD220, which can be cleaved into the following 2 chains: Insulin receptor subunit alpha and Insulin receptor subunit beta. INSR is a tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains carry the insulin-binding regions, while the beta chains carry the kinase domain. Forms a hybrid receptor with IGF1R, the hybrid is a tetramer consisting of 1 alpha chain and 1 beta chain of INSR and 1 alpha chain and 1 beta chain of IGF1R. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short of INSR has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, INSR binds IGF1.

Insulin R References

Insulin R Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Recombinant human insulin (Hefei Tianmai Biotechnology) Approved Hefei Tianmai Biotechnology Development Co Ltd Mainland China Diabetes Mellitus s:46:"Hefei Tianmai Biotechnology Development Co Ltd"; 2018-04-28 Diabetes Mellitus Details
Insulin aspart biosimilar (Gan & Lee) Approved Gan & Lee Biotech Mainland China Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 s:17:"Gan & Lee Biotech"; 2020-06-05 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Details
Recombinant human insulin (SciGen) Approved Generex Biotechnology Corp Recojet India Diabetes Mellitus s:4:"null"; 2004-12-01 Diabetes Mellitus Details
Recombinant insulin glargine (Gan & Lee) Approved Gan & Lee Biotech 长秀霖, Basalin Mainland China Diabetes Mellitus s:25:"Gan & Lee Pharmaceuticals"; 2005-05-10 Diabetes Mellitus, Type 1; Diabetes Mellitus Details
Insulin biosimilar (Harvest Moon Pharmaceuticals) Approved Harvest Moon N; Diabetes Mellitus Details
Recombinant human insulin (Biocon) Approved Biocon Insugen India Diabetes Mellitus s:6:"Biocon"; 2004-11-10 Diabetes Mellitus Details
Insulin aspart biosimilar (Sanofi) SAR-341402; SAR-Asp Approved Sanofi EU Diabetes Mellitus s:14:"Sanofi-Aventis"; 2020-06-25 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin biosimilar (Julphar) Approved Julphar (Gulf Pharmaceutical Industries) Julphar Insulin R Tunisia Diabetes Mellitus s:40:"Julphar (Gulf Pharmaceutical Industries)"; 2013-10-01 Diabetes Mellitus Details
Insulin glargine biosimilar (Biocon) MYL-1501D Approved Mylan, Fujifilm Corp, Biocon Biopharmaceuticals Basalog, Semglee United States Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 s:25:"Mylan Pharmaceuticals Inc"; 2009-01-01 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin biosimilar (Sedico) Approved Sedico Insulin H bio R Egypt Diabetes Mellitus s:6:"Sedico"; 2013-02-01 Diabetes Mellitus Details
Insulin human HR-1799 Approved Sanofi Deutschland Insulin Human Winthrop United States Diabetes Mellitus s:22:"Baxter Healthcare Corp"; 1997-02-21 Diabetes Mellitus Details
Recombinant human insulin (Tonghua Dongbao Pharmaceutical) Approved Tonghua Dongbao Pharmaceutical Co Ltd 甘舒霖 Mainland China Diabetes Mellitus s:37:"Tonghua Dongbao Pharmaceutical Co Ltd"; 1998-01-01 Diabetes Mellitus Details
Oral insulin (Generex Biotechnology) Approved Generex Biotechnology Corp Oralin, Oralgen, Oral-lyn, Recosulin Ecuador Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 s:4:"null"; 2005-01-01 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Details
Bacitracin Approved Pfizer Pharmaceuticals Ltd (China) Bacterial Infections s:34:"Pfizer Pharmaceuticals Ltd (China)"; 1945-01-01 Bacterial Infections Details
Insul 30/70 biosimilar (Popular Pharmaceuticals) Approved Popular Pharmaceuticals Insul 30-70 N; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational Details
Isophane Protamine Recombinant Human Insulin biosimilar (Popular Pharmaceuticals) Approved Popular Pharmaceuticals Insulin N Bangladesh Diabetes Mellitus s:23:"Popular Pharmaceuticals"; 2013-01-01 Diabetes Mellitus Details
Recombinant human insulin (United Laboratories International Holdings) Approved Zhuhai United Laboratories (Zhongshan) Co Ltd 优思灵, Uslin Mainland China Diabetes Mellitus s:53:"Zhongshan Branch of Zhuhai United Laboratories Co Ltd"; 2009-11-25 Diabetes Mellitus Details
Insulin lispro biosimilar (Sanofi) SAR-342434 Approved Sanofi Admelog United States Diabetes Mellitus, Type 2 s:23:"Sanofi-Aventis U.S. Llc"; 2017-07-18 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Isophane Protamine Recombinant Human Insulin (BIOTON) Approved Bioton Mainland China Diabetes Mellitus s:6:"Bioton"; 2013-03-29 Diabetes Mellitus Details
Human insulin biosimilar (Square Pharmaceuticals) Approved Square Pharmaceuticals Ansulin Bangladesh Diabetes Mellitus s:22:"Square Pharmaceuticals"; 2013-01-01 Diabetes Mellitus Details
Insulin glargine biosimilar (Wockhardt) Approved Wockhardt Bio Ag Glaritus, Glaritus Cart, Glaritus DispoPen India Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 s:9:"Wockhardt"; 2013-01-01 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Isophane Protamine Recombinant Human Insulin Injection (Shenzhen Kexing Biotech) Approved Shenzhen Kexing Biological Engineering Co Ltd 苏泌啉恩 Mainland China Diabetes Mellitus s:45:"Shenzhen Kexing Biological Engineering Co Ltd"; 2003-02-24 Diabetes Mellitus Details
Recombinant insulin (Horizon Pharma/Ibatech) Approved Savient Pharmaceuticals Poland Diabetes Mellitus, Type 1 s:4:"null"; 2002-07-01 Diabetes Mellitus, Type 1 Details
Insulin glargine biosimilar (Getz Pharma) Approved Getz Pharma Basagine N; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Details
Insulin biosimilar (Wockhardt) Approved Wockhardt Wosulin, Wosulin®-R, Wosulin Pen, Wosulin Pen Royale India Diabetes Mellitus, Type 1 s:9:"Wockhardt"; 2003-10-01 Diabetes Mellitus, Type 1; Diabetes Mellitus Details
Recombinant human insulin (Incepta) Approved Incepta Pharmaceuticals Maxsulin Bangladesh Diabetes Mellitus s:23:"Incepta Pharmaceuticals"; 2012-01-01 Diabetes Mellitus Details
Human insulin biosimilar (MJ Biopharm) Approved Mj Biopharm Pvt Biosulin Russian Federation Diabetes Mellitus s:15:"Mj Biopharm Pvt"; 2005-12-01 Diabetes Mellitus Details
Insulin glargine biosimilar (Incepta Pharmaceuticals) Approved Incepta Pharmaceuticals Bangladesh Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 s:23:"Incepta Pharmaceuticals"; 2012-08-01 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Details
Rinsulin NPH (Geropharm) Approved Geropharm Rinsulin NPH Russian Federation Diabetes Mellitus s:9:"Geropharm"; 2012-10-01 Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin biosimilar (Popular Pharmaceuticals) Approved Popular Pharmaceuticals Insul R Bangladesh Diabetes Mellitus s:23:"Popular Pharmaceuticals"; 2013-01-01 Diabetes Mellitus Details
Insulin lispro protamine biosimilar (Gan & Lee Pharmaceuticals) Approved Gan & Lee Biotech 速秀霖25, Suxiulin25 Mainland China Diabetes Mellitus s:25:"Gan & Lee Pharmaceuticals"; 2014-05-09 Diabetes Mellitus Details
Isophane Protamine Recombinant Human Insulin(Novo Nordisk) Approved Novo Nordisk (China)Pharmaceuticals Co Ltd N; Diabetes Mellitus Details
Insulin human(Organon France) Approved Organon France EU Diabetes Mellitus s:14:"Organon France"; 1999-11-03 Diabetes Mellitus Details
Insulin human (inhalation powder) SAR-439065 Approved Mannkind Corporation Afresa, Afrezza, Technosphere Insulin System United States Diabetes Mellitus, Type 2 s:13:"Mannkind Corp"; 2014-06-27 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Asthma; Pulmonary Disease, Chronic Obstructive Details
Isophane Insulin(Polish Society of Diabetology) Approved Polish Society of Diabetology N; Diabetes Mellitus Details
Recombinant human insulin (Shenzhen Kexing Biotech) Approved Shenzhen Kexing Biological Engineering Co Ltd 苏泌啉, Su Bi Lin Mainland China Diabetes Mellitus s:45:"Shenzhen Kexing Biological Engineering Co Ltd"; 2002-06-10 Diabetes Mellitus Details
Insulin glulisine HMR-1964 Approved Sanofi 艾倍得, Apidra Mainland China Diabetes Mellitus s:31:"Sanofi-Aventis Deutschland Gmbh"; 2004-04-16 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Recombinant lispro insulin biosimilar (Gan & Lee) Approved Gan & Lee Pharmaceuticals Mainland China Diabetes Mellitus s:25:"Gan & Lee Pharmaceuticals"; 2006-01-19 Diabetes Mellitus Details
Insulin detemir NN-304 Approved Novo Nordisk A/S 诺和平, Levemir Japan Diabetes Mellitus s:16:"Novo Nordisk A/S"; 2004-06-01 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin degludec/Liraglutide NN-9068 Approved Novo Nordisk A/S Xultophy, iDegLira Japan Diabetes Mellitus, Type 2 s:16:"Novo Nordisk A/S"; 2014-09-18 Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin lispro LYSPRO; LY-900027; LY-275585; Lys-B28; Pro-B29 Approved Eli Lilly And Company Humalog, 优泌乐, Eglucent, Liprolog, Liumjev United States Diabetes Mellitus s:20:"Eli Lilly And Co Ltd"; 1996-04-30 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin glargine biosimilar (LG Life Sciences) Approved Lg Life Sciences Ltd Basugine N; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Details
Insulin glargine biosimilar (Zhuhai United) Approved Zhuhai United Laboratories Co Ltd Mainland China Diabetes Mellitus s:33:"Zhuhai United Laboratories Co Ltd"; 2016-12-23 Diabetes Mellitus Details
Insulin glargine/Lixisenatide HOE-901/AVE-0010 Approved Sanofi Soliqua, Suliqua, iGlarLixi EU Diabetes Mellitus, Type 2 s:14:"Sanofi-Aventis"; 2016-11-21 Diabetes Mellitus, Type 2 Details
Recombinant Human Insulin (Wanbang Pharma) Approved Jiangsu Wanbang Biopharmaceuticals Mainland China Diabetes Mellitus s:35:"Jiangsu Wanbang Biopharmaceuticals "; 2003-08-29 Diabetes Mellitus Details
Insulin glargine U-300; Gla-100; Gla-300; Hoe-901; Hoe-71GT; HOE901-U300 Approved Sanofi 来得时, Lantus, Toujeo, Lantus XR, Optisulin Japan Diabetes Mellitus s:6:"Sanofi"; 2000-04-20 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hyperglycemia; Diabetes Mellitus Details
Insulin glargine biosimilar (YiChang HEC ChangJiang Pharmaceutical) Approved Guangdong Dongyangguang Pharmaceutical Co Ltd Mainland China Diabetes Mellitus s:44:"Yichang Hec Changjiang Pharmaceutical Co Ltd"; 2020-06-05 Diabetes Mellitus Details
Insulin glargine biosimilar (Tonghua Dongbao Pharmaceutical) Approved Tonghua Dongbao Pharmaceutical Co Ltd 长舒霖 Mainland China Diabetes Mellitus s:37:"Tonghua Dongbao Pharmaceutical Co Ltd"; 2019-12-06 Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin degludec/Insulin aspart NN-1045; NN-5401; NN-1250/Insulin aspart Approved Novo Nordisk A/S 诺和佳, Ryzodeg Mainland China Diabetes Mellitus s:16:"Novo Nordisk A/S"; 2012-12-25 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin aspart NN-1218; INA-X14; Insulin X14 Approved Novo Nordisk A/S Novolog, NovoRapid, NovoLog FlexPen, NovoMix, Fiasp, 诺和锐, NovoRapid/NovoLog Japan Diabetes Mellitus s:16:"Novo Nordisk A/S"; 1999-09-07 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Ceritinib LDK-378; NVP-LDK378; NVP-LDK378-NX Approved Novartis Pharma Ag 赞可达, Zykadia Mainland China Carcinoma, Non-Small-Cell Lung s:22:"Novartis Europharm Ltd"; 2014-04-29 Stomach Neoplasms; Glioblastoma; Adenocarcinoma of Lung; Pancreatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Hepatic Insufficiency; Lymphoma, Large-Cell, Anaplastic; Carcinoma, Squamous Cell; Granuloma, Plasma Cell; Esophageal adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma Details
Insulin degludec NN-1250; Insulin-454 Approved Novo Nordisk A/S 诺和达, Tresiba Mainland China Diabetes Mellitus, Type 2 s:16:"Novo Nordisk A/S"; 2012-09-28 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin glargine biosimilar (Lilly/Boehringer Ingelheim) LY-2963016; LY2963016-U-100; LY2963016-U-200 Approved Boehringer Ingelheim Gmbh, Eli Lilly And Company Abasria, Basaglar, Abasaglar Japan Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 s:21:"Eli Lilly And Company"; 2014-09-09 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin human (rDNA origin, Lilly) S-3300; U-500R; LY-041001 Approved Eli Lilly And Company 优泌林, Humulin, Humulin R, Humulin R Pen, Humulin R Kwikpen Japan Diabetes Mellitus s:21:"Eli Lilly And Company"; 1982-10-28 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin human (rDNA origin, Novo Nordisk) NN-729 Approved Novo Nordisk A/S Mixtard, Novolin, Actraphane, Insulatard Japan Diabetes Mellitus s:16:"Novo Nordisk A/S"; 1983-08-30 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Pulmonary Disease, Chronic Obstructive; Diabetes Mellitus Details
Isophane Insulin Approved Jiangsu Wanbang Biopharmaceuticals 万苏林 Mainland China Diabetes Mellitus s:35:"Jiangsu Wanbang Biopharmaceuticals "; 1997-01-01 Diabetes Mellitus Details
Rosinsulin Approved Medsintez N; Diabetes Mellitus Details
Isophane Protamine Recombinant Human Insulin (Hefei Tianmai Biotechnology) Approved Hefei Tianmai Biotechnology Development Co Ltd Mainland China Diabetes Mellitus s:46:"Hefei Tianmai Biotechnology Development Co Ltd"; 2019-09-05 Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details

Insulin R Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Recombinant insulin aspart biosimilar (Biogenomics) Phase 3 Clinical Biogenomics Diabetes Mellitus, Type 2 Details
重组赖精胰岛素(合肥天麦) Phase 3 Clinical Hefei Tianmai Biotechnology Development Co Ltd Diabetes Mellitus Details
Alirinetide GM-6; GM-600; GM-602; GM-603; GM-604; GM-605; GM-606; GM-607; GM-608; GM-609 Phase 2 Clinical Genervon Biopharmaceuticals Llc Stroke; Parkinson Disease; Amyotrophic Lateral Sclerosis Details
Isophane Protamine Recombinant Human Insulin (Hec Pharm Co) Phase 1 Clinical Hec Pharm Co Ltd Diabetes Mellitus Details
Insulin lispro/Insulin glargine Phase 2 Clinical Adocia Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Details
Insulin biosimilar (Valin Technologies) Van-101 Phase 3 Clinical Valin Technologies Diabetes Mellitus Details
Insulin glargine biosimilar (Geropharm) Phase 3 Clinical Geropharm Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
CB-4211 CB-4211 Phase 1 Clinical Cohbar Non-alcoholic Fatty Liver Disease; Obesity Details
Insulin Aspart 30 (Liaoning Bo'Ao Bio-Pharmaceutical) Liaoning Bo'Ao Bio-Pharmaceutical Co Ltd Details
AKP-11 AKP-11 Phase 2 Clinical Akaal Pharma Psoriasis Details
Insulin detemir biosimilar (Tonghua Dongbao Pharmaceutical) Phase 1 Clinical Tonghua Dongbao Biotechnology Co Ltd Diabetes Mellitus Details
Fast-acting human insulin (Adocia) Hinsbet-U500; BioChaperone-222 Phase 2 Clinical Adocia Diabetes Mellitus, Type 1 Details
Dulaglutide/Basal insulin Fc Phase 1 Clinical Eli Lilly And Company Diabetes Mellitus Details
Insulin glargine biosimilar (Valin Technologies) Phase 1 Clinical Valin Technologies Diabetes Mellitus Details
Oral insulin (Purede) Clinical Puredel Diabetes Mellitus Details
Pegylated recombinant human insulin (Chongqing Fujin Biomedical) CA001 Phase 1 Clinical Chongqing Fujin Biological Medicine Co Ltd Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin aspart (Jilin Jinsheng) Phase 1 Clinical Jilin Jinsheng Pharmaceutical Co Ltd Diabetes Mellitus Details
Recombinant human insulin (Eastgate Biotech) EGP-1214 Clinical Eastgate Biotech Prediabetic State; Diabetes Mellitus, Type 2 Details
Insulin lispro (Diasome Pharmaceuticals) Phase 2 Clinical Diasome Pharmaceuticals Diabetes Mellitus, Type 1 Details
Basal insulin Fc (Eli Lilly) Phase 1 Clinical Eli Lilly And Company Diabetes Mellitus Details
Insulin biosimilar (University of Montreal Health Centre) Phase 1 Clinical University Of Montreal Health Centre Glaucoma Details
Insulin aspart biosimilar (Biocon/Mylan) MYL-1601D Phase 3 Clinical Biocon Diabetes Mellitus, Type 1 Details
Insulin aspart biosimilar (Geropharm) GP-40071; GP-40081 Phase 3 Clinical Geropharm Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin mouth rinse (EastGate Biotech) Phase 3 Clinical Genome Pharmaceuticals, Eastgate Biotech Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Alzheimer Disease Details
XOMA-358 XOMA-247; RZ358; RZ-358; XPA.15.247; XOMA-358 Phase 2 Clinical Xoma Congenital Hyperinsulinism; Hypoglycemia; Hyperinsulinism Details
Insulin glargine biosimilar (Wanbang Biochemical) Phase 3 Clinical Jiangsu Wanbang Biopharmaceuticals Diabetes Mellitus, Type 2 Details
Insulin Aspart 30 (Yichang Hec Changjiang Pharmaceutical) Yichang Hec Changjiang Pharmaceutical Co Ltd Details
Long-acting basal insulin analogue LAI-287; NN-1436; NN-1956; OI-287GT; 148-0287-A; Insulin-287; NNC0148-0287 C; NNC-0148-0000-0287; Long-acting-insulin-287; Long-acting basal insulin analogue Phase 3 Clinical Novo Nordisk A/S Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
PE-0139 PE-0139 Phase 2 Clinical Phasebio Diabetes Mellitus, Type 2 Details
NP-01 (Medesis Pharma SA) NP01 Phase 1 Clinical Medesis Pharma Sa Diabetes Mellitus, Type 2 Details
Insulin glargine (Hefei Tianmai) Phase 1 Clinical Hefei Tianmai Biotechnology Development Co Ltd Diabetes Mellitus Details
Insulin oral (Diabetology) DTY-001 Phase 2 Clinical Diabetology Ltd Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Details
Insulin biosimilars (Bioton) Clinical Bioton Diabetes Mellitus Details
Recombinant insulin glargine (Chongqing Fujin Biological Medicine) Phase 3 Clinical Chongqing Fujin Biological Medicine Co Ltd Diabetes Mellitus, Type 2 Details
Recombinant human insulin biosimilar (Rechon Life Sciences) Phase 3 Clinical Rechon Life Science Diabetes Mellitus, Type 1 Details
Pramlintide/Insulin ADO-09 Phase 2 Clinical Adocia Diabetes Mellitus, Type 1 Details
Oral insulin-338-C10 LAI-338; NN-1438; NN-1953; OI-338GT; NNC0123-0338; Insulin-338-GIPET-I; Oral insulin 338 C10 Phase 2 Clinical Merrion Pharmaceuticals, Novo Nordisk A/S Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Recombinant human insulin (Nutrinia) NTRA-9620 Phase 3 Clinical Nutrinia Diabetes Mellitus, Type 2; Short Bowel Syndrome Details
DM199 DM-99; DM-199 Phase 2 Clinical Diamedica Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Arthritis, Rheumatoid; Kidney Diseases; Stroke; Alzheimer Disease; Renal Insufficiency, Chronic; Diabetes Mellitus Details
Insulin (Coremed) Phase 1 Clinical Coremed Diabetes Mellitus Details
Recombinant human insulin (Zhejiang Hisun Pharmaceutical) Zhejiang Hisun Pharmaceutical Co Ltd Details
Intranasal insulin (Johns Hopkins University) Phase 2 Clinical Johns Hopkins University Neurocognitive Disorders; Multiple Sclerosis Details
Insulin Aspart (Beijing Sl Pharmaceutical) Phase 3 Clinical Beijing Sl Pharmaceutical Co Ltd Diabetes Mellitus, Type 2 Details
Recombinant human insulin(30/70) (Zhejiang Hisun Pharmaceutical) Phase 3 Clinical Zhejiang Hisun Pharmaceutical Co Ltd Diabetes Mellitus, Type 2 Details
Mixed Protamine Zinc Recombinant Insulin Lispro Injection(25R)(Tonghua Dongbao) Phase 3 Clinical Tonghua Dongbao Pharmaceutical Co Ltd Diabetes Mellitus, Type 2; Diabetes Mellitus Details
HM-12460A HM-12470; HM-12470A; SAR-440067 Phase 1 Clinical Hanmi Pharmaceutical Co Ltd Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 Details
Insulins (Halozyme) Aspart-PH20; Lispro-PH20; Insulin-PH20; rHuPH20/insulin; Analog insulin-PH20 Phase 2 Clinical Halozyme Therapeutics Inc Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dermatitis, Allergic Contact; Diabetes Mellitus Details
Ultra fast-acting insulin (Adocia) BC-222-Insulin-Lispro; BC-106-Insulin-Lispro; THDB-0206; THDB0206 Phase 3 Clinical Adocia Diabetes Mellitus, Type 1; Diabetic Foot; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Insulin lispro biosimilar (Wanbang Biopharma) Phase 3 Clinical Jiangsu Wanbang Biopharmaceuticals Diabetes Mellitus Details
Insulin Glargine (Zhejiang Hisun Pharmaceutical) HS004 Phase 3 Clinical Zhejiang Hisun Pharmaceutical Co Ltd Diabetes Mellitus Details
INS-068 INS-068 Phase 2 Clinical Chengdu Suncadia Medicine Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd, Jiangsu Hengrui Medicine Co Ltd Diabetes Mellitus, Type 2 Details
AB-101 AB-101 Phase 2 Clinical Rezolute, Ipr Pharmaceuticals Diabetes Mellitus, Type 1; Breast Neoplasms; Sexual Dysfunction, Physiological; Lymphoma, Non-Hodgkin; Mental Disorders Details
Insulin (Oramed Pharmaceuticals) ORMD-0801 Phase 3 Clinical Oramed Pharmaceuticals Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Non-alcoholic Fatty Liver Disease; Diabetes Mellitus Details
Insulin icodec 148-0287-A; Insulin-287; LAI-287; Long-acting basal insulin analogue; Long-acting-insulin-287; NN-1436; NN-1956; NNC-0148-0000-0287; NNC0148-0287 C; OI-287GT Phase 3 Clinical Novo Nordisk A/S Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus Details
Isophane Protamine Recombinant Human Insulin (Jilin Huisheng Biological ) Phase 3 Clinical Jilin Huisheng Biological Pharmaceutical Co Ltd Diabetes Mellitus, Type 2 Details
Semaglutide/Insulin 287 NNC0148-0287sema Phase 1 Clinical Novo Nordisk A/S Diabetes Mellitus, Type 2 Details

This web search service is supported by Google Inc.

totop